More black men to benefit from prostate cancer screening trial
The UK government is investing £18 million into the 'Transform' trial to increase prostate cancer screening participation among black men aged 45-74. This initiative seeks to determine if genetic testing and MRI scans can improve screening accuracy compared to traditional PSA tests.
Why it matters
Black men face double the risk of prostate cancer compared to the general population, making targeted research essential for reducing health disparities.
Share Save Add as preferred on Google Philippa Roxby Health reporter Getty Images Tens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK to find better ways of testing for the disease.
The report presents the government's health initiative and the medical context objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in